---
schema_version: "secwatch.filing_event.v1"
accession: "0001558370-23-014412"
form_type: "8-K"
ticker: "MGTX"
cik: "0001735438"
company_name: "MeiraGTx Holdings plc"
filed_at: "2023-08-10T23:59:59+00:00"
generated_at: "2026-06-11T18:26:25.365141+00:00"
event_type: "earnings"
sentiment: "neutral"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# MeiraGTx Q2 net loss $29.6M; Phase 3 XLRP trial enrollment surpassed; secures $25M note amendment

## Summary
- Q2 2023 net loss $29.6M ($0.53/share) vs $34.0M ($0.76) YoY; license revenue $3.5M (down from $10.8M).
- Cash $92.8M at June 30, 2023; with Janssen receivables, runway into Q2 2025.
- Phase 3 LUMEOS trial of bota-vec for XLRP enrollment target surpassed; BLA submission expected in 2024.
- Consent and Amendment allows MeiraGTx to request $25M additional notes at its discretion (previously Perceptive's).
- Shannon manufacturing facility received first commercial MIA authorization for gene therapy QC testing in Ireland.

## SEC filing metadata
- accession: 0001558370-23-014412
- form_type: 8-K
- ticker: MGTX
- cik: 0001735438
- company_name: MeiraGTx Holdings plc
- filed_at: 2023-08-10T23:59:59+00:00
- event_type: earnings
- sentiment: neutral
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 1.01, 2.02, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1735438/000155837023014412/0001558370-23-014412-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1735438/000155837023014412/mgtx-20230810x8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001558370-23-014412
- JSON: https://secwatch.observer/filing/0001558370-23-014412.json
- Plain text: https://secwatch.observer/filing/0001558370-23-014412.txt

## Key facts
- Debt Financings
  MeiraGTx Holdings plc amended debt of additional $25 million notes issuance with Perceptive Credit Holdings III, LP.
  - Principal: additional $25 million notes issuance
  - Counterparty: Perceptive Credit Holdings III, LP
  - Event: amendment
  source text: Under the Consent and Amendment, the Company may request in its sole discretion, and Perceptive has agreed to subscribe to purchase upon such request, an additional $25 million notes issuance (the “Tranche 2 Notes”) at any time before August 2, 2024 subject to the terms of the Note Purchase Agreement.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1735438/000155837023014412/0001558370-23-014412-index.htm
- Earnings Releases
  MeiraGTx Holdings plc reported financial results for second quarter ended June 30, 2023.
  - Period: second quarter ended June 30, 2023
  - Result: reported results
  source text: On August 10, 2023, the Company issued a press release announcing its financial results for the quarter ended June 30, 2023.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1735438/000155837023014412/0001558370-23-014412-index.htm
- Material Agreements
  MeiraGTx Holdings plc amended Consent and Amendment with Perceptive Credit Holdings III, LP valued at $25 million (effective 2023-08-10).
  - Action: amendment
  - Agreement: notes offering
  - Counterparty: Perceptive Credit Holdings III, LP
  - Value: $25 million
  - Effective: 2023-08-10
  source text: On August 10, 2023, MeiraGTx Holdings plc (the “Company”), as issuer, and its wholly-owned subsidiaries MeiraGTx UK II Limited, a company incorporated in England and Wales (“MeiraGTx UK II”), and MeiraGTx Ireland DAC, a designated activity company limited by shares incorporated in Ireland (“MeiraGTx Ireland,” and together with MeiraGTx UK II, the “Subsidiary Guarantors”), entered into a Consent and Amendment to Amended and Restated Note Purchase Agreement and Guaranty (the “Consent and Amendment”) by and among the Company, the Subsidiary Guarantors, the noteholders and other parties from time to time party thereto, and Perceptive Credit Holdings III, LP, as administrative agent and noteholder (“Perceptive”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1735438/000155837023014412/0001558370-23-014412-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.